REV CARDIOVASC MED 润色咨询

Reviews in Cardiovascular Medicine

出版年份：2000 年文章数：435 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：0.0% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2102434, encodeId=729f2102434d7, content=您好 有没有要求您填写PRISMA NMA checklist啊 这个该怎么填, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b556516610, createdName=ms4000000762993253, createdTime=Thu Nov 24 16:35:05 CST 2022, time=2022-11-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1210930, encodeId=72fa1210930fd, content=请问Pending APC Confirm是什么状态？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4ac5598839, createdName=ms6000000288353789, createdTime=Wed Apr 13 19:41:27 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588113, encodeId=2f8058811329, content=审稿一个月，被拒，不过提了很多很好的建议, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/01/7380d2e4458b894c6b85eada6c979fed.jpg, createdBy=89f02391547, createdName=123351fcm65(暂无昵称), createdTime=Fri Apr 03 00:00:00 CST 2020, time=2020-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236436, encodeId=3c711236436c0, content=投了一周了，一直是pending pre check，这是什么状态？意思是还在编辑的手里吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Wed Aug 03 19:32:21 CST 2022, time=2022-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852711, encodeId=95ab852e11cd, content=投了5天就收到了杂志社的反馈邮件，帮我送审了2位审稿人，专业外审通过之后，在语言审核环节，杂志社的耐心很好，给了我多次修改润色的机会； , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4765414076, createdName=ms1875852553058278, createdTime=Fri Jul 19 18:17:10 CST 2019, time=2019-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947136, encodeId=0dac94e13603, content=最新：<br>期刊官网：https://rcm.imrpress.com/EN/2153-8174/home.shtml<br>投稿链接：https://jour.ipublishment.com/imr/access/login, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4584844622, createdName=1884434752m, createdTime=Wed Mar 10 15:16:29 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100636, encodeId=ce0111006366f, content=方法部分什么时候需要详细描述，什么时候可以简写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570859, encodeId=b8555e085991, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：这个刊物效率很好，基本审稿1个月内，出版3个月内，适合应急。我投的第一篇10天就录用了，3个审稿人,关键反馈效率特别高，每次发邮件都是当天回复我信息，比其他一些杳无音信的期刊强万倍了 <br> <br> 另外这个期刊的准确的官网是：https://rcm.imrpress.org/EN/2153-8174/home.shtml <br> 投稿链接是：https://www.editorialmanager.com/rcm/default.aspx <br> <br> 请叫我雷锋，嘿嘿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6dc2488490, createdName=aliceyang2018_63388764, createdTime=Mon May 13 16:18:00 CST 2019, time=2019-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100635, encodeId=b8f31100635d0, content=什么叫实验室常规使用方法？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590338, encodeId=2594590338d9, content=基础文章，无外审，直接拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/01/7380d2e4458b894c6b85eada6c979fed.jpg, createdBy=89f02391547, createdName=123351fcm65(暂无昵称), createdTime=Wed May 06 00:00:00 CST 2020, time=2020-05-06, status=1, ipAttribution=)]
    2022-11-24 ms4000000762993253 来自山东省

    您好 有没有要求您填写PRISMA NMA checklist啊 这个该怎么填

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2102434, encodeId=729f2102434d7, content=您好 有没有要求您填写PRISMA NMA checklist啊 这个该怎么填, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b556516610, createdName=ms4000000762993253, createdTime=Thu Nov 24 16:35:05 CST 2022, time=2022-11-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1210930, encodeId=72fa1210930fd, content=请问Pending APC Confirm是什么状态？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4ac5598839, createdName=ms6000000288353789, createdTime=Wed Apr 13 19:41:27 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588113, encodeId=2f8058811329, content=审稿一个月，被拒，不过提了很多很好的建议, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/01/7380d2e4458b894c6b85eada6c979fed.jpg, createdBy=89f02391547, createdName=123351fcm65(暂无昵称), createdTime=Fri Apr 03 00:00:00 CST 2020, time=2020-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236436, encodeId=3c711236436c0, content=投了一周了，一直是pending pre check，这是什么状态？意思是还在编辑的手里吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Wed Aug 03 19:32:21 CST 2022, time=2022-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852711, encodeId=95ab852e11cd, content=投了5天就收到了杂志社的反馈邮件，帮我送审了2位审稿人，专业外审通过之后，在语言审核环节，杂志社的耐心很好，给了我多次修改润色的机会； , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4765414076, createdName=ms1875852553058278, createdTime=Fri Jul 19 18:17:10 CST 2019, time=2019-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947136, encodeId=0dac94e13603, content=最新：<br>期刊官网：https://rcm.imrpress.com/EN/2153-8174/home.shtml<br>投稿链接：https://jour.ipublishment.com/imr/access/login, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4584844622, createdName=1884434752m, createdTime=Wed Mar 10 15:16:29 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100636, encodeId=ce0111006366f, content=方法部分什么时候需要详细描述，什么时候可以简写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570859, encodeId=b8555e085991, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：这个刊物效率很好，基本审稿1个月内，出版3个月内，适合应急。我投的第一篇10天就录用了，3个审稿人,关键反馈效率特别高，每次发邮件都是当天回复我信息，比其他一些杳无音信的期刊强万倍了 <br> <br> 另外这个期刊的准确的官网是：https://rcm.imrpress.org/EN/2153-8174/home.shtml <br> 投稿链接是：https://www.editorialmanager.com/rcm/default.aspx <br> <br> 请叫我雷锋，嘿嘿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6dc2488490, createdName=aliceyang2018_63388764, createdTime=Mon May 13 16:18:00 CST 2019, time=2019-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100635, encodeId=b8f31100635d0, content=什么叫实验室常规使用方法？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590338, encodeId=2594590338d9, content=基础文章，无外审，直接拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/01/7380d2e4458b894c6b85eada6c979fed.jpg, createdBy=89f02391547, createdName=123351fcm65(暂无昵称), createdTime=Wed May 06 00:00:00 CST 2020, time=2020-05-06, status=1, ipAttribution=)]
    2022-04-13 ms6000000288353789

    请问Pending APC Confirm是什么状态？

    14

    展开14条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2102434, encodeId=729f2102434d7, content=您好 有没有要求您填写PRISMA NMA checklist啊 这个该怎么填, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b556516610, createdName=ms4000000762993253, createdTime=Thu Nov 24 16:35:05 CST 2022, time=2022-11-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1210930, encodeId=72fa1210930fd, content=请问Pending APC Confirm是什么状态？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4ac5598839, createdName=ms6000000288353789, createdTime=Wed Apr 13 19:41:27 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588113, encodeId=2f8058811329, content=审稿一个月，被拒，不过提了很多很好的建议, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/01/7380d2e4458b894c6b85eada6c979fed.jpg, createdBy=89f02391547, createdName=123351fcm65(暂无昵称), createdTime=Fri Apr 03 00:00:00 CST 2020, time=2020-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236436, encodeId=3c711236436c0, content=投了一周了，一直是pending pre check，这是什么状态？意思是还在编辑的手里吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Wed Aug 03 19:32:21 CST 2022, time=2022-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852711, encodeId=95ab852e11cd, content=投了5天就收到了杂志社的反馈邮件，帮我送审了2位审稿人，专业外审通过之后，在语言审核环节，杂志社的耐心很好，给了我多次修改润色的机会； , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4765414076, createdName=ms1875852553058278, createdTime=Fri Jul 19 18:17:10 CST 2019, time=2019-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947136, encodeId=0dac94e13603, content=最新：<br>期刊官网：https://rcm.imrpress.com/EN/2153-8174/home.shtml<br>投稿链接：https://jour.ipublishment.com/imr/access/login, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4584844622, createdName=1884434752m, createdTime=Wed Mar 10 15:16:29 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100636, encodeId=ce0111006366f, content=方法部分什么时候需要详细描述，什么时候可以简写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570859, encodeId=b8555e085991, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：这个刊物效率很好，基本审稿1个月内，出版3个月内，适合应急。我投的第一篇10天就录用了，3个审稿人,关键反馈效率特别高，每次发邮件都是当天回复我信息，比其他一些杳无音信的期刊强万倍了 <br> <br> 另外这个期刊的准确的官网是：https://rcm.imrpress.org/EN/2153-8174/home.shtml <br> 投稿链接是：https://www.editorialmanager.com/rcm/default.aspx <br> <br> 请叫我雷锋，嘿嘿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6dc2488490, createdName=aliceyang2018_63388764, createdTime=Mon May 13 16:18:00 CST 2019, time=2019-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100635, encodeId=b8f31100635d0, content=什么叫实验室常规使用方法？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590338, encodeId=2594590338d9, content=基础文章，无外审，直接拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/01/7380d2e4458b894c6b85eada6c979fed.jpg, createdBy=89f02391547, createdName=123351fcm65(暂无昵称), createdTime=Wed May 06 00:00:00 CST 2020, time=2020-05-06, status=1, ipAttribution=)]
    2020-04-03 123351fcm65(暂无昵称)

    审稿一个月，被拒，不过提了很多很好的建议

    2

    展开2条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2102434, encodeId=729f2102434d7, content=您好 有没有要求您填写PRISMA NMA checklist啊 这个该怎么填, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b556516610, createdName=ms4000000762993253, createdTime=Thu Nov 24 16:35:05 CST 2022, time=2022-11-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1210930, encodeId=72fa1210930fd, content=请问Pending APC Confirm是什么状态？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4ac5598839, createdName=ms6000000288353789, createdTime=Wed Apr 13 19:41:27 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588113, encodeId=2f8058811329, content=审稿一个月，被拒，不过提了很多很好的建议, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/01/7380d2e4458b894c6b85eada6c979fed.jpg, createdBy=89f02391547, createdName=123351fcm65(暂无昵称), createdTime=Fri Apr 03 00:00:00 CST 2020, time=2020-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236436, encodeId=3c711236436c0, content=投了一周了，一直是pending pre check，这是什么状态？意思是还在编辑的手里吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Wed Aug 03 19:32:21 CST 2022, time=2022-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852711, encodeId=95ab852e11cd, content=投了5天就收到了杂志社的反馈邮件，帮我送审了2位审稿人，专业外审通过之后，在语言审核环节，杂志社的耐心很好，给了我多次修改润色的机会； , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4765414076, createdName=ms1875852553058278, createdTime=Fri Jul 19 18:17:10 CST 2019, time=2019-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947136, encodeId=0dac94e13603, content=最新：<br>期刊官网：https://rcm.imrpress.com/EN/2153-8174/home.shtml<br>投稿链接：https://jour.ipublishment.com/imr/access/login, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4584844622, createdName=1884434752m, createdTime=Wed Mar 10 15:16:29 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100636, encodeId=ce0111006366f, content=方法部分什么时候需要详细描述，什么时候可以简写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570859, encodeId=b8555e085991, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：这个刊物效率很好，基本审稿1个月内，出版3个月内，适合应急。我投的第一篇10天就录用了，3个审稿人,关键反馈效率特别高，每次发邮件都是当天回复我信息，比其他一些杳无音信的期刊强万倍了 <br> <br> 另外这个期刊的准确的官网是：https://rcm.imrpress.org/EN/2153-8174/home.shtml <br> 投稿链接是：https://www.editorialmanager.com/rcm/default.aspx <br> <br> 请叫我雷锋，嘿嘿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6dc2488490, createdName=aliceyang2018_63388764, createdTime=Mon May 13 16:18:00 CST 2019, time=2019-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100635, encodeId=b8f31100635d0, content=什么叫实验室常规使用方法？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590338, encodeId=2594590338d9, content=基础文章，无外审，直接拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/01/7380d2e4458b894c6b85eada6c979fed.jpg, createdBy=89f02391547, createdName=123351fcm65(暂无昵称), createdTime=Wed May 06 00:00:00 CST 2020, time=2020-05-06, status=1, ipAttribution=)]
    2022-08-03 ms6000000673439938

    投了一周了，一直是pending pre check，这是什么状态？意思是还在编辑的手里吗？

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2102434, encodeId=729f2102434d7, content=您好 有没有要求您填写PRISMA NMA checklist啊 这个该怎么填, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b556516610, createdName=ms4000000762993253, createdTime=Thu Nov 24 16:35:05 CST 2022, time=2022-11-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1210930, encodeId=72fa1210930fd, content=请问Pending APC Confirm是什么状态？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4ac5598839, createdName=ms6000000288353789, createdTime=Wed Apr 13 19:41:27 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588113, encodeId=2f8058811329, content=审稿一个月，被拒，不过提了很多很好的建议, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/01/7380d2e4458b894c6b85eada6c979fed.jpg, createdBy=89f02391547, createdName=123351fcm65(暂无昵称), createdTime=Fri Apr 03 00:00:00 CST 2020, time=2020-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236436, encodeId=3c711236436c0, content=投了一周了，一直是pending pre check，这是什么状态？意思是还在编辑的手里吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Wed Aug 03 19:32:21 CST 2022, time=2022-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852711, encodeId=95ab852e11cd, content=投了5天就收到了杂志社的反馈邮件，帮我送审了2位审稿人，专业外审通过之后，在语言审核环节，杂志社的耐心很好，给了我多次修改润色的机会； , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4765414076, createdName=ms1875852553058278, createdTime=Fri Jul 19 18:17:10 CST 2019, time=2019-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947136, encodeId=0dac94e13603, content=最新：<br>期刊官网：https://rcm.imrpress.com/EN/2153-8174/home.shtml<br>投稿链接：https://jour.ipublishment.com/imr/access/login, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4584844622, createdName=1884434752m, createdTime=Wed Mar 10 15:16:29 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100636, encodeId=ce0111006366f, content=方法部分什么时候需要详细描述，什么时候可以简写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570859, encodeId=b8555e085991, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：这个刊物效率很好，基本审稿1个月内，出版3个月内，适合应急。我投的第一篇10天就录用了，3个审稿人,关键反馈效率特别高，每次发邮件都是当天回复我信息，比其他一些杳无音信的期刊强万倍了 <br> <br> 另外这个期刊的准确的官网是：https://rcm.imrpress.org/EN/2153-8174/home.shtml <br> 投稿链接是：https://www.editorialmanager.com/rcm/default.aspx <br> <br> 请叫我雷锋，嘿嘿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6dc2488490, createdName=aliceyang2018_63388764, createdTime=Mon May 13 16:18:00 CST 2019, time=2019-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100635, encodeId=b8f31100635d0, content=什么叫实验室常规使用方法？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590338, encodeId=2594590338d9, content=基础文章，无外审，直接拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/01/7380d2e4458b894c6b85eada6c979fed.jpg, createdBy=89f02391547, createdName=123351fcm65(暂无昵称), createdTime=Wed May 06 00:00:00 CST 2020, time=2020-05-06, status=1, ipAttribution=)]
    2019-07-19 ms1875852553058278

    投了5天就收到了杂志社的反馈邮件，帮我送审了2位审稿人，专业外审通过之后，在语言审核环节，杂志社的耐心很好，给了我多次修改润色的机会；

    3

    展开3条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2102434, encodeId=729f2102434d7, content=您好 有没有要求您填写PRISMA NMA checklist啊 这个该怎么填, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b556516610, createdName=ms4000000762993253, createdTime=Thu Nov 24 16:35:05 CST 2022, time=2022-11-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1210930, encodeId=72fa1210930fd, content=请问Pending APC Confirm是什么状态？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4ac5598839, createdName=ms6000000288353789, createdTime=Wed Apr 13 19:41:27 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588113, encodeId=2f8058811329, content=审稿一个月，被拒，不过提了很多很好的建议, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/01/7380d2e4458b894c6b85eada6c979fed.jpg, createdBy=89f02391547, createdName=123351fcm65(暂无昵称), createdTime=Fri Apr 03 00:00:00 CST 2020, time=2020-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236436, encodeId=3c711236436c0, content=投了一周了，一直是pending pre check，这是什么状态？意思是还在编辑的手里吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Wed Aug 03 19:32:21 CST 2022, time=2022-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852711, encodeId=95ab852e11cd, content=投了5天就收到了杂志社的反馈邮件，帮我送审了2位审稿人，专业外审通过之后，在语言审核环节，杂志社的耐心很好，给了我多次修改润色的机会； , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4765414076, createdName=ms1875852553058278, createdTime=Fri Jul 19 18:17:10 CST 2019, time=2019-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947136, encodeId=0dac94e13603, content=最新：<br>期刊官网：https://rcm.imrpress.com/EN/2153-8174/home.shtml<br>投稿链接：https://jour.ipublishment.com/imr/access/login, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4584844622, createdName=1884434752m, createdTime=Wed Mar 10 15:16:29 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100636, encodeId=ce0111006366f, content=方法部分什么时候需要详细描述，什么时候可以简写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570859, encodeId=b8555e085991, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：这个刊物效率很好，基本审稿1个月内，出版3个月内，适合应急。我投的第一篇10天就录用了，3个审稿人,关键反馈效率特别高，每次发邮件都是当天回复我信息，比其他一些杳无音信的期刊强万倍了 <br> <br> 另外这个期刊的准确的官网是：https://rcm.imrpress.org/EN/2153-8174/home.shtml <br> 投稿链接是：https://www.editorialmanager.com/rcm/default.aspx <br> <br> 请叫我雷锋，嘿嘿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6dc2488490, createdName=aliceyang2018_63388764, createdTime=Mon May 13 16:18:00 CST 2019, time=2019-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100635, encodeId=b8f31100635d0, content=什么叫实验室常规使用方法？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590338, encodeId=2594590338d9, content=基础文章，无外审，直接拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/01/7380d2e4458b894c6b85eada6c979fed.jpg, createdBy=89f02391547, createdName=123351fcm65(暂无昵称), createdTime=Wed May 06 00:00:00 CST 2020, time=2020-05-06, status=1, ipAttribution=)]
    2021-03-10 1884434752m

    最新：
    期刊官网：https://rcm.imrpress.com/EN/2153-8174/home.shtml
    投稿链接：https://jour.ipublishment.com/imr/access/login

    2

    展开2条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2102434, encodeId=729f2102434d7, content=您好 有没有要求您填写PRISMA NMA checklist啊 这个该怎么填, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b556516610, createdName=ms4000000762993253, createdTime=Thu Nov 24 16:35:05 CST 2022, time=2022-11-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1210930, encodeId=72fa1210930fd, content=请问Pending APC Confirm是什么状态？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4ac5598839, createdName=ms6000000288353789, createdTime=Wed Apr 13 19:41:27 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588113, encodeId=2f8058811329, content=审稿一个月，被拒，不过提了很多很好的建议, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/01/7380d2e4458b894c6b85eada6c979fed.jpg, createdBy=89f02391547, createdName=123351fcm65(暂无昵称), createdTime=Fri Apr 03 00:00:00 CST 2020, time=2020-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236436, encodeId=3c711236436c0, content=投了一周了，一直是pending pre check，这是什么状态？意思是还在编辑的手里吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Wed Aug 03 19:32:21 CST 2022, time=2022-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852711, encodeId=95ab852e11cd, content=投了5天就收到了杂志社的反馈邮件，帮我送审了2位审稿人，专业外审通过之后，在语言审核环节，杂志社的耐心很好，给了我多次修改润色的机会； , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4765414076, createdName=ms1875852553058278, createdTime=Fri Jul 19 18:17:10 CST 2019, time=2019-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947136, encodeId=0dac94e13603, content=最新：<br>期刊官网：https://rcm.imrpress.com/EN/2153-8174/home.shtml<br>投稿链接：https://jour.ipublishment.com/imr/access/login, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4584844622, createdName=1884434752m, createdTime=Wed Mar 10 15:16:29 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100636, encodeId=ce0111006366f, content=方法部分什么时候需要详细描述，什么时候可以简写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570859, encodeId=b8555e085991, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：这个刊物效率很好，基本审稿1个月内，出版3个月内，适合应急。我投的第一篇10天就录用了，3个审稿人,关键反馈效率特别高，每次发邮件都是当天回复我信息，比其他一些杳无音信的期刊强万倍了 <br> <br> 另外这个期刊的准确的官网是：https://rcm.imrpress.org/EN/2153-8174/home.shtml <br> 投稿链接是：https://www.editorialmanager.com/rcm/default.aspx <br> <br> 请叫我雷锋，嘿嘿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6dc2488490, createdName=aliceyang2018_63388764, createdTime=Mon May 13 16:18:00 CST 2019, time=2019-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100635, encodeId=b8f31100635d0, content=什么叫实验室常规使用方法？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590338, encodeId=2594590338d9, content=基础文章，无外审，直接拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/01/7380d2e4458b894c6b85eada6c979fed.jpg, createdBy=89f02391547, createdName=123351fcm65(暂无昵称), createdTime=Wed May 06 00:00:00 CST 2020, time=2020-05-06, status=1, ipAttribution=)]
    2021-12-27 MS68862005

    方法部分什么时候需要详细描述，什么时候可以简写？

    2

    展开2条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2102434, encodeId=729f2102434d7, content=您好 有没有要求您填写PRISMA NMA checklist啊 这个该怎么填, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b556516610, createdName=ms4000000762993253, createdTime=Thu Nov 24 16:35:05 CST 2022, time=2022-11-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1210930, encodeId=72fa1210930fd, content=请问Pending APC Confirm是什么状态？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4ac5598839, createdName=ms6000000288353789, createdTime=Wed Apr 13 19:41:27 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588113, encodeId=2f8058811329, content=审稿一个月，被拒，不过提了很多很好的建议, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/01/7380d2e4458b894c6b85eada6c979fed.jpg, createdBy=89f02391547, createdName=123351fcm65(暂无昵称), createdTime=Fri Apr 03 00:00:00 CST 2020, time=2020-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236436, encodeId=3c711236436c0, content=投了一周了，一直是pending pre check，这是什么状态？意思是还在编辑的手里吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Wed Aug 03 19:32:21 CST 2022, time=2022-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852711, encodeId=95ab852e11cd, content=投了5天就收到了杂志社的反馈邮件，帮我送审了2位审稿人，专业外审通过之后，在语言审核环节，杂志社的耐心很好，给了我多次修改润色的机会； , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4765414076, createdName=ms1875852553058278, createdTime=Fri Jul 19 18:17:10 CST 2019, time=2019-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947136, encodeId=0dac94e13603, content=最新：<br>期刊官网：https://rcm.imrpress.com/EN/2153-8174/home.shtml<br>投稿链接：https://jour.ipublishment.com/imr/access/login, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4584844622, createdName=1884434752m, createdTime=Wed Mar 10 15:16:29 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100636, encodeId=ce0111006366f, content=方法部分什么时候需要详细描述，什么时候可以简写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570859, encodeId=b8555e085991, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：这个刊物效率很好，基本审稿1个月内，出版3个月内，适合应急。我投的第一篇10天就录用了，3个审稿人,关键反馈效率特别高，每次发邮件都是当天回复我信息，比其他一些杳无音信的期刊强万倍了 <br> <br> 另外这个期刊的准确的官网是：https://rcm.imrpress.org/EN/2153-8174/home.shtml <br> 投稿链接是：https://www.editorialmanager.com/rcm/default.aspx <br> <br> 请叫我雷锋，嘿嘿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6dc2488490, createdName=aliceyang2018_63388764, createdTime=Mon May 13 16:18:00 CST 2019, time=2019-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100635, encodeId=b8f31100635d0, content=什么叫实验室常规使用方法？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590338, encodeId=2594590338d9, content=基础文章，无外审，直接拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/01/7380d2e4458b894c6b85eada6c979fed.jpg, createdBy=89f02391547, createdName=123351fcm65(暂无昵称), createdTime=Wed May 06 00:00:00 CST 2020, time=2020-05-06, status=1, ipAttribution=)]
    2019-05-13 aliceyang2018_63388764

    审稿速度:1.0 | 投稿命中率:75.0
    经验分享：这个刊物效率很好，基本审稿1个月内，出版3个月内，适合应急。我投的第一篇10天就录用了，3个审稿人,关键反馈效率特别高，每次发邮件都是当天回复我信息，比其他一些杳无音信的期刊强万倍了

    另外这个期刊的准确的官网是：https://rcm.imrpress.org/EN/2153-8174/home.shtml
    投稿链接是：https://www.editorialmanager.com/rcm/default.aspx

    请叫我雷锋，嘿嘿

    5

    展开5条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2102434, encodeId=729f2102434d7, content=您好 有没有要求您填写PRISMA NMA checklist啊 这个该怎么填, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b556516610, createdName=ms4000000762993253, createdTime=Thu Nov 24 16:35:05 CST 2022, time=2022-11-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1210930, encodeId=72fa1210930fd, content=请问Pending APC Confirm是什么状态？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4ac5598839, createdName=ms6000000288353789, createdTime=Wed Apr 13 19:41:27 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588113, encodeId=2f8058811329, content=审稿一个月，被拒，不过提了很多很好的建议, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/01/7380d2e4458b894c6b85eada6c979fed.jpg, createdBy=89f02391547, createdName=123351fcm65(暂无昵称), createdTime=Fri Apr 03 00:00:00 CST 2020, time=2020-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236436, encodeId=3c711236436c0, content=投了一周了，一直是pending pre check，这是什么状态？意思是还在编辑的手里吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Wed Aug 03 19:32:21 CST 2022, time=2022-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852711, encodeId=95ab852e11cd, content=投了5天就收到了杂志社的反馈邮件，帮我送审了2位审稿人，专业外审通过之后，在语言审核环节，杂志社的耐心很好，给了我多次修改润色的机会； , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4765414076, createdName=ms1875852553058278, createdTime=Fri Jul 19 18:17:10 CST 2019, time=2019-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947136, encodeId=0dac94e13603, content=最新：<br>期刊官网：https://rcm.imrpress.com/EN/2153-8174/home.shtml<br>投稿链接：https://jour.ipublishment.com/imr/access/login, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4584844622, createdName=1884434752m, createdTime=Wed Mar 10 15:16:29 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100636, encodeId=ce0111006366f, content=方法部分什么时候需要详细描述，什么时候可以简写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570859, encodeId=b8555e085991, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：这个刊物效率很好，基本审稿1个月内，出版3个月内，适合应急。我投的第一篇10天就录用了，3个审稿人,关键反馈效率特别高，每次发邮件都是当天回复我信息，比其他一些杳无音信的期刊强万倍了 <br> <br> 另外这个期刊的准确的官网是：https://rcm.imrpress.org/EN/2153-8174/home.shtml <br> 投稿链接是：https://www.editorialmanager.com/rcm/default.aspx <br> <br> 请叫我雷锋，嘿嘿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6dc2488490, createdName=aliceyang2018_63388764, createdTime=Mon May 13 16:18:00 CST 2019, time=2019-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100635, encodeId=b8f31100635d0, content=什么叫实验室常规使用方法？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590338, encodeId=2594590338d9, content=基础文章，无外审，直接拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/01/7380d2e4458b894c6b85eada6c979fed.jpg, createdBy=89f02391547, createdName=123351fcm65(暂无昵称), createdTime=Wed May 06 00:00:00 CST 2020, time=2020-05-06, status=1, ipAttribution=)]
    2021-12-27 MS54455111222

    什么叫实验室常规使用方法？

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2102434, encodeId=729f2102434d7, content=您好 有没有要求您填写PRISMA NMA checklist啊 这个该怎么填, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b556516610, createdName=ms4000000762993253, createdTime=Thu Nov 24 16:35:05 CST 2022, time=2022-11-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1210930, encodeId=72fa1210930fd, content=请问Pending APC Confirm是什么状态？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4ac5598839, createdName=ms6000000288353789, createdTime=Wed Apr 13 19:41:27 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588113, encodeId=2f8058811329, content=审稿一个月，被拒，不过提了很多很好的建议, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/01/7380d2e4458b894c6b85eada6c979fed.jpg, createdBy=89f02391547, createdName=123351fcm65(暂无昵称), createdTime=Fri Apr 03 00:00:00 CST 2020, time=2020-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236436, encodeId=3c711236436c0, content=投了一周了，一直是pending pre check，这是什么状态？意思是还在编辑的手里吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Wed Aug 03 19:32:21 CST 2022, time=2022-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852711, encodeId=95ab852e11cd, content=投了5天就收到了杂志社的反馈邮件，帮我送审了2位审稿人，专业外审通过之后，在语言审核环节，杂志社的耐心很好，给了我多次修改润色的机会； , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4765414076, createdName=ms1875852553058278, createdTime=Fri Jul 19 18:17:10 CST 2019, time=2019-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947136, encodeId=0dac94e13603, content=最新：<br>期刊官网：https://rcm.imrpress.com/EN/2153-8174/home.shtml<br>投稿链接：https://jour.ipublishment.com/imr/access/login, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4584844622, createdName=1884434752m, createdTime=Wed Mar 10 15:16:29 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100636, encodeId=ce0111006366f, content=方法部分什么时候需要详细描述，什么时候可以简写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570859, encodeId=b8555e085991, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：这个刊物效率很好，基本审稿1个月内，出版3个月内，适合应急。我投的第一篇10天就录用了，3个审稿人,关键反馈效率特别高，每次发邮件都是当天回复我信息，比其他一些杳无音信的期刊强万倍了 <br> <br> 另外这个期刊的准确的官网是：https://rcm.imrpress.org/EN/2153-8174/home.shtml <br> 投稿链接是：https://www.editorialmanager.com/rcm/default.aspx <br> <br> 请叫我雷锋，嘿嘿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6dc2488490, createdName=aliceyang2018_63388764, createdTime=Mon May 13 16:18:00 CST 2019, time=2019-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100635, encodeId=b8f31100635d0, content=什么叫实验室常规使用方法？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590338, encodeId=2594590338d9, content=基础文章，无外审，直接拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/01/7380d2e4458b894c6b85eada6c979fed.jpg, createdBy=89f02391547, createdName=123351fcm65(暂无昵称), createdTime=Wed May 06 00:00:00 CST 2020, time=2020-05-06, status=1, ipAttribution=)]
    2020-05-06 123351fcm65(暂无昵称)

    基础文章，无外审，直接拒了

    1

    展开1条回复
共125条页码: 2/13页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分